articles
- Role of host factors on the regulation of Tat-mediated HIV-1 transcription. 23:4079-4090. 2017
- Molecular mechanics. 20:3281-3292. 2014
- Phase 1 safety, tolerability and pharmacokinetics of 3K3A-APC in healthy adult volunteers. 19:7479-7485. 2013
- Preclinical safety and pharmacokinetic profile of 3K3A-APC, a novel, modified activated protein C for ischemic stroke. 18:4215-4222. 2012
- A role for rev-erb alpha ligands in the regulation of adipogenesis. 17:320-324. 2011
- Structure-based vaccine design in hiv: Blind men and the elephant?. 16:3744-3753. 2010
- Multivalent and multifunctional ligands to β-amyloid. 15:637-658. 2009
- Presentation of lipid antigens by CD1 glycoproteins. 15:3311-3317. 2009
- Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses. 14:3219-3230. 2008
- Rational modifications of hiv-1 envelope glycoproteins for immunogen design. 13:213-227. 2007
- Integrative functional assays, chemical genomics and high throughput screening: Harnessing signal transduction pathways to a common HTS readout. 12:1717-1729. 2006
- Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseases. 12:161-171. 2006
- TLR signaling pathways: Opportunities for activation and blockade in pursuit of therapy. 12:4123-4134. 2006
- Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. 11:1255-1265. 2005
- Adjunctive therapy for percutaneous revascularization in acute myocardial infarction. 10:399-405. 2004
- Oleamide: an endogenous sleep-inducing lipid and prototypical member of a new class of biological signaling molecules. 4:303-314. 1998